CDC mandates Ebola attestation for US-bound flights - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CDC mandates Ebola attestation for US-bound flights

  • By

  • Teraya Smith

  • October 29, 2026

  • 3 min

Share

Clinical Scorecard: CDC mandates Ebola attestation for US-bound flights

At a Glance

CategoryDetail
ConditionEbola disease risk associated with recent presence in the Democratic Republic of the Congo (DRC)
Key MechanismsThe order uses a 21-day travel-history attestation, corresponding to Ebola disease’s maximum incubation period, to reduce the risk of introduction through air travel.
Target PopulationAll individuals aboard covered flights to the United States, including US citizens, nationals, lawful permanent residents, foreign travelers, operating crew, and deadhead personnel.
Care SettingInternational air travel to the United States; airlines and aircraft operators verify attestations before boarding.

Key Highlights

  • The requirement takes effect November 3, 2026, at 11:59 p.m. EST, and is scheduled to remain in effect until December 18, 2026, unless changed.
  • Travelers must attest that they were not physically present in the DRC during the preceding 21 days; presence includes transit and airport connections.
  • The order covers commercial, private, and general aviation flights, including flights connecting through the United States to other destinations.
  • Travelers who have been in the DRC may board beginning on Day 22 after departure, with departure counted as Day 0.
  • Operators must verify attestations before boarding, retain them for at least 42 days after arrival, and provide them to federal authorities upon request.

Guideline-Based Recommendations

Diagnosis

    Management

    • Passengers must complete a paper or electronic attestation confirming they were not physically present in the DRC during the previous 21 days.
    • Airlines and aircraft operators must prevent boarding without a valid attestation unless a US government exemption applies.
    • Travelers who have been in the DRC must remain outside the United States for 21 days after departure; eligible travelers may board on Day 22 if they meet other travel requirements.
    • Parents or authorized adults must complete attestations for travelers younger than 18; an authorized representative may complete one for a person unable to sign because of a disability.

    Monitoring & Follow-up

    • Operators must retain completed attestations for at least 42 days after arrival and provide them to federal authorities upon request.

    Risks

    • Knowingly providing false information may result in federal prosecution, criminal fines, or imprisonment under 18 U.S.C. § 1001.
    • Exemptions may include government-authorized transportation of patients with Ebola disease or CDC-granted exceptions for humanitarian or other important government considerations.

    Patient & Prescribing Data

    All travelers and personnel aboard covered flights departing foreign countries for the United States at or after the effective time.

    This is a travel attestation and boarding restriction, not a treatment protocol. The 21-day period is based on the maximum Ebola disease incubation period.

    Clinical Best Practices

    • Count any physical presence in the DRC, including air, land, or sea transit and airport connections, toward the travel-history restriction.
    • For the 21-day period after leaving the DRC, count the departure date as Day 0 and the first full calendar day outside the country as Day 1.
    • Confirm that an attestation is completed before boarding; apply only exemptions authorized by the US government.

    Related Resources & Content

    Original Source(s)

    Related Content